Regulation of circulating sclerostin levels by sex steroids in women and in men

Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women

(2010) Matthew T. Drake et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal Women

(2010) Faryal S. Mirza et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The −9247 T/C polymorphism in the SOST upstream regulatory region that potentially affects C/EBPα and FOXA1 binding is associated with osteoporosis

(2009) Qing-Yang Huang et al.   BONE

Characterization of Wnt/β-catenin signalling in osteoclasts in multiple myeloma

(2009) Ya-Wei Qiang et al.   BRITISH JOURNAL OF HAEMATOLOGY

WNT/β-Catenin Signaling Is Involved in Regulation of Osteoclast Differentiation by Human Immunodeficiency Virus Protease Inhibitor Ritonavir

(2008) Rozbeh Modarresi et al.   AMERICAN JOURNAL OF PATHOLOGY

Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease

(2008) Ann E. Kearns et al.   ENDOCRINE REVIEWS

Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength

(2008) Xiaodong Li et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis*

(2008) Xiaodong Li et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Impact on Bone of an Estrogen Receptor-α Gene Loss of Function Mutation

(2008) Eric P. Smith et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo

(2008) J. A. Clowes et al.   OSTEOPOROSIS INTERNATIONAL